News
MSU researchers use virtual reality to modernize health care training
Henry Ford Health + Michigan State University Health Sciences has named the award recipients of the 2024 Cancer Seed Funding Program. Building on the success of the 2022 and 2023 cancer research pilot and integration award funding initiatives, this year the program awarded 14 new cancer research awards totaling $700,000.
“We are committed to supporting collaborative research to create a national and international destination for access to the most advanced cancer therapies and interventions,” said Ben Movsas, Henry Ford + MSU Cancer Committee co-chair, Henry Ford Cancer medical director and radiation oncology chair. “Our Henry Ford + MSU cancer researchers are demonstrating the power of coming together, with examples of previous recipients moving forward with federally funded research proposals.”
Henry Ford Health, MSU announce 2024 cancer research award recipients
Henry Ford Health + Michigan State University Health Sciences has named the award recipients of the 2024 Cancer Seed Funding Program. Building on the success of the 2022 and 2023 cancer research pilot and integration award funding initiatives, this year the program awarded 14 new cancer research awards totaling $700,000.
“We are committed to supporting collaborative research to create a national and international destination for access to the most advanced cancer therapies and interventions,” said Ben Movsas, Henry Ford + MSU Cancer Committee co-chair, Henry Ford Cancer medical director and radiation oncology chair. “Our Henry Ford + MSU cancer researchers are demonstrating the power of coming together, with examples of previous recipients moving forward with federally funded research proposals.”
Fighting prostate cancer, from farm to table, at MSU
With a nod to bringing local, fresh ingredients directly to our dinner plates, Michigan State University researchers will soon be applying their own farm-to-table approach to the fight against prostate cancer. From therapeutic ingredient production to research and testing — it’s all happening at MSU.
The special ingredient in this approach is promethium-149, or 149Pm.
This isotope has promising qualities for targeted radiotherapy — a process that delivers radioactive isotopes directly to cancer cells to damage their DNA.